• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艰难梭菌感染患者关键路径的影响评估:三级转诊中心的前后分析。

Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center.

机构信息

Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Roma, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Roma, Italy.

出版信息

Int J Infect Dis. 2019 Mar;80:105-110. doi: 10.1016/j.ijid.2019.01.025. Epub 2019 Jan 22.

DOI:10.1016/j.ijid.2019.01.025
PMID:30682499
Abstract

BACKGROUND

Clostridium Difficile Infections (CDIs) have been increasing both in incidence and in severity, representing a big public health concern.

AIM

The aim of this study was to evaluate the impact of a recently implemented Critical Pathway (CP) focused on patients with CDI in an Italian Teaching Hospital.

METHODS

The CP implementation consisted of intervention aimed to faster diagnosis and appropriateness in admission and discharge point of care; activation of a multidisciplinary team; staff training; information to patients and caregivers. In a pre-post retrospective observational study, volume, process and outcome indicators were analyzed.

FINDINGS

A total of 228 patients (128 in 2013 and 100 in 2016) were included. A decrease in the absolute number of access to the Emergency Department (p=0.02) and an increase in hospitalization in more appropriate ward (ie gastroenterology ward, p<0.001) were found. The median hospital length of stay decreased from 20.5 (12.5-31) days in 2013 to 16.5 (7-31) days in 2016 (p=0.05). With regards to outcome indicators, an increase of discharge to home and a decrease of discharge to long term facilities were showed (p=0.01 both). Despite a reduction, no statically significant differences in mortality between 2013 and 2016 were revealed by the analysis.

CONCLUSION

In conclusion, we found quality improvement in patient hospital management. Our experience confirms that the implementation of the CP increases the appropriateness in hospital quality of care.

摘要

背景

艰难梭菌感染(CDI)的发病率和严重程度都在增加,这是一个重大的公共卫生问题。

目的

本研究旨在评估在意大利一所教学医院实施的一项针对 CDI 患者的重点治疗路径(CP)对患者管理的影响。

方法

CP 的实施包括旨在加快诊断和入院及出院时机的适当性的干预措施;激活多学科团队;员工培训;向患者和护理人员提供信息。在回顾性的前后观察研究中,分析了数量、过程和结果指标。

结果

共纳入 228 例患者(2013 年 128 例,2016 年 100 例)。发现急诊就诊的绝对人数减少(p=0.02),更多患者入住更合适的病房(即胃肠科病房,p<0.001)。2013 年住院时间中位数为 20.5(12.5-31)天,2016 年为 16.5(7-31)天(p=0.05)。在结果指标方面,出院回家的比例增加,而长期护理机构的出院比例下降(两者均为 p=0.01)。尽管有所减少,但分析并未显示 2013 年和 2016 年之间死亡率有统计学意义的差异。

结论

总之,我们发现患者住院管理质量有所提高。我们的经验证实,CP 的实施提高了医院护理质量的适当性。

相似文献

1
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center.艰难梭菌感染患者关键路径的影响评估:三级转诊中心的前后分析。
Int J Infect Dis. 2019 Mar;80:105-110. doi: 10.1016/j.ijid.2019.01.025. Epub 2019 Jan 22.
2
The burden of Clostridium difficile in surgical patients in the United States.美国外科手术患者中艰难梭菌的负担。
Surg Infect (Larchmt). 2007 Dec;8(6):557-66. doi: 10.1089/sur.2006.062.
3
Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.入院时检测和隔离艰难梭菌携带者对艰难梭菌感染发生率的影响:一项准实验对照研究。
JAMA Intern Med. 2016 Jun 1;176(6):796-804. doi: 10.1001/jamainternmed.2016.0177.
4
Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.加拿大一家大型教学医院在临床药学和医学微生物学参与下对艰难梭菌感染管理政策的评估。
J Clin Pharm Ther. 2015 Dec;40(6):655-60. doi: 10.1111/jcpt.12329. Epub 2015 Nov 7.
5
Hospital Clostridium difficile infection (CDI) incidence as a risk factor for hospital-associated CDI.医院艰难梭菌感染(CDI)发病率作为医院相关CDI的一个风险因素。
Am J Infect Control. 2016 Jul 1;44(7):825-9. doi: 10.1016/j.ajic.2016.01.006. Epub 2016 Mar 2.
6
The burden of healthcare-associated Clostridium difficile infection in a non-metropolitan setting.非都市地区医疗保健相关艰难梭菌感染的负担
J Hosp Infect. 2017 Apr;95(4):387-393. doi: 10.1016/j.jhin.2016.12.009. Epub 2016 Dec 18.
7
Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection.医院病房抗生素处方与艰难梭菌感染的风险。
JAMA Intern Med. 2015 Apr;175(4):626-33. doi: 10.1001/jamainternmed.2014.8273.
8
Clostridium difficile infection incidence: impact of audit and feedback programme to improve room cleaning.艰难梭菌感染发病率:审核和反馈方案对改善病房清洁的影响。
J Hosp Infect. 2016 Feb;92(2):161-6. doi: 10.1016/j.jhin.2015.11.001. Epub 2015 Nov 11.
9
Kick the Bucket: One Hospital System's Journey to Reduce Clostridium Difficile.一命呜呼:一家医院系统减少艰难梭菌感染的历程
J Emerg Nurs. 2017 Nov;43(6):519-525. doi: 10.1016/j.jen.2017.02.003. Epub 2017 Apr 4.
10
Hospital Clostridium difficile Infection Rates and Prediction of Length of Stay in Patients Without C. difficile Infection.医院艰难梭菌感染率及无艰难梭菌感染患者住院时间的预测
Infect Control Hosp Epidemiol. 2016 Apr;37(4):404-10. doi: 10.1017/ice.2015.340. Epub 2016 Feb 9.

引用本文的文献

1
Definition of a tool to assess shared decision-making (SDM) on women with breast cancer: A value-based approach.一种评估乳腺癌患者共同决策(SDM)的工具的定义:基于价值的方法。
Health Sci Rep. 2022 Sep 13;5(5):e817. doi: 10.1002/hsr2.817. eCollection 2022 Sep.
2
Agomelatine Drug Utilisation Study in Selected European Countries: A Multinational, Observational Study to Assess Effectiveness of Risk-Minimisation Measures.欧洲部分国家阿戈美拉汀药物利用研究:一项评估风险最小化措施有效性的多国观察性研究。
Pharmaceut Med. 2019 Aug;33(4):311-319. doi: 10.1007/s40290-019-00291-2.
3
Ivabradine drug utilization study in five European countries: A multinational, retrospective, observational study to assess effectiveness of risk-minimization measures.
伊伐布雷定药物利用研究在五个欧洲国家:一项评估风险最小化措施有效性的多国家、回顾性、观察性研究。
Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1470-1479. doi: 10.1002/pds.4880. Epub 2019 Sep 4.